Evommune, Inc. Common Stock (EVMN)

Cost of Revenue

$0.00

TTM · Period ending: · USD

EVMN logo

EVMN Cost of Revenue

Latest reported$0.00
EVMN TTM Cost of Revenue ($596.00K → $0.00)
High-resolution chart · PNG

EVMN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Evommune, Inc. Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
375,000
752,000
752,000
752,000
702,000
596,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.